Our scientific publications in high-quality journals reflect the quality of the innovative research in Entasis’ laboratories.
Jacobsson S, Golparian D, Oxelbark J, Franceschi F, Brown D, Louie A, Drusano G and Unemo M
Frontiers in Pharmacology (2022)
Jacobsson S, Kularatne R, Kittiyaowamarn R, Maseko V, Paopang P, Sangprasert P, Sirivongrangson P, Piddock L, Wi T, Alirol E, and Unemo M
Antimicrobial Agents and Chemotherapy (2019)
Unemo M, Ahlstrand J, Sanchez-Buso, Day M, Aanensen D, Golparian D, Jacobsson S, Cole MJ and European Collaborative Group
Journal of Antimicrobial Chemotherapy (2021)
Newman LM, Kankam M, Nakamura A, Conrad T, Mueller J, O'Donnell J, Osborn BL, Gu K, Saviolakis GA
Antimicrobial Agents and Chemotherapy (2021)
Jacobsson S, Golparian D, Oxelbark J, Alirol FF, Gustafsson TN, Brown D, Louie A, Drusano G and Unemo M
Frontiers in Pharmacology (2021)
Le W, Su X, Lou X, Li X, Gong X, Wang B, Genco CA, Mueller JP and Rice PA
Antimicrobial Agents and Chemotherapy (2021)
Theuretzbacher U, Barbee L, Connolly K, Drusano G, Fernandes P, Hook E, Jerse A, O'Donnell J, Unemo M, Van Bambeke F, VanScoy B, Warn P, Werth BJ, Franceschi F, and Alirol E
Clinical Microbiology and Infection (2020)
Bradford PA, Miller AA, O’Donnell J, and Mueller JP
ACS Infectious Diseases (2020)
Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP
Determination of MIC quality control ranges for the novel gyrase inhibitor, zoliflodacin
Journal of Clinical Microbiology (2019)
Taylor SN, Marrazzo J, Batteiger BE, Hook EW, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, and Mueller J
Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea
New England Journal of Medicine (2018)